IONIS PHARMACEUTICALS INC
IONS
78 insider filings · Latest: Jul 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 5 11:14 PM | Allene M. DiazDirector | Sale | 54,878 | $79.35 | $4.4M | 3,811(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Sale | 20,106 | $79.40 | $1.6M | 22,541(D) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Sale | 85,089 | $79.23 | $6.7M | 80,554(D) | View → |
| Mar 4, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Sale | 439 | $80.00 | $35.1K | 4,347(I) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Sale | 6,220 | $79.72 | $495.9K | 4,347(I) | View → |
| Mar 3, 2026 | Mar 3 10:52 PM | BENNETT C FRANK | Proposed Sale | 85,089 | $82.93 | $7.1M | — | View → |
| Mar 3, 2026 | Mar 3 10:51 PM | LOSCALZO JOSEPH | Proposed Sale | 24,000 | $80.00 | $1.9M | — | View → |
| Mar 3, 2026 | Mar 3 10:43 PM | Baroldi Mariana | Proposed Sale | 8,198 | $80.00 | $655.8K | — | View → |
| Mar 3, 2026 | Mar 3 10:42 PM | Baroldi Joseph | Proposed Sale | 4,096 | $79.36 | $325.1K | — | View → |
| Mar 3, 2026 | Mar 3 10:35 PM | KLEIN JOSEPH III | Proposed Sale | 65,345 | $77.07 | $5.0M | — | View → |
| Mar 3, 2026 | Mar 3 10:34 PM | Devers Shannon L. | Proposed Sale | 39,014 | $79.50 | $3.1M | — | View → |
| Feb 13, 2026 | Feb 14 12:40 AM | Eric SwayzeEVP Research | Sale | 15,642 | $81.76 | $1.3M | 32,105(D) | View → |
| Feb 11, 2026 | Feb 14 12:40 AM | Lynne B ParshallDirector | Sale | 5,000 | $82.72 | $413.6K | 56,344(D) | View → |
| Feb 13, 2026 | Feb 13 9:04 PM | Swayze Eric | Proposed Sale | 15,642 | $81.65 | $1.3M | — | View → |
| Feb 11, 2026 | Feb 11 9:02 PM | PARSHALL B LYNNE | Proposed Sale | 10,000 | $82.74 | $827.4K | — | View → |
| Feb 6, 2026 | Feb 10 10:04 PM | Brett P MoniaDirector, Chief Executive Officer | Sale | 29,430 | $85.79 | $2.5M | 254,497(D) | View → |
| Feb 6, 2026 | Feb 6 9:09 PM | Monia Brett P | Proposed Sale | 290,203 | $85.55 | $24.8M | — | View → |
| Feb 2, 2026 | Feb 4 9:06 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Sale | 85,089 | $82.93 | $7.1M | 80,293(D) | View → |
| Jan 30, 2026 | Feb 3 1:52 AM | Eric SwayzeEVP Research | Sale | 6,179 | $82.93 | $512.4K | 47,747(D) | View → |
| Jan 30, 2026 | Feb 3 1:52 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Sale | 6,179 | $83.45 | $515.6K | 69,702(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 5 11:14 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Option Exercise | 20,106 | $52.87 | 8,877(D) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Mar 4, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 439 | $56.78 | 3,866(I) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 1,699 | $56.78 | 4,104(I) | View → |
| Feb 2, 2026 | Feb 4 9:06 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Michael J. YangDirector | Option Exercise | 1,930 | — | 7,150(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Option Exercise | 21,477 | — | 386(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Grant/Award | 35,700 | $0.00 | 611(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Option Exercise | 21,685 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Option Exercise | 21,473 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Grant/Award | 156,585 | $0.00 | 205,719(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 89,145 | — | 163,014(D) | View → |
| Jan 2, 2026 | Jan 21 1:20 AM | Holly B. KordasiewiczEVP, Chief Development Officer | Grant/Award | 7,500 | $79.67 | 16,600(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Holly B. KordasiewiczEVP, Chief Development Officer | Option Exercise | 11,119 | — | 20,830(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Holly B. KordasiewiczEVP, Chief Development Officer | Grant/Award | 24,900 | — | 45,730(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Option Exercise | 7,013 | — | 29,664(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Grant/Award | 35,475 | $0.00 | 37,725(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | HOUGEN ELIZABETH LEVP, Finance & CFO | Option Exercise | 28,729 | — | 55,940(D) | View → |